InvaGen to continue to hold shares in Avenue Therapeutics: Cipla
Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…
Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…
Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…
The Department of Pharmaceuticals (DoP) has come out with a draft policy to catalyse research and development (R&D) and innovation in…
Introduction The Medical Device industry is highly capital intensive with a long gestation period and requires development and induction of new technologies.…